Clinical trials for Yellow fever

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Yellow fever. For all clinical trials, go to clinical trials search

This list shows clinical trials for Yellow fever

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Yellow fever
Title Recruitment status Location
Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever Vaccines Not recruiting United Kingdom
The Use of a Forecasting System for Predicting Exacerbations of COPD Not recruiting United Kingdom
The Development of a Human Model of Respiratory Syncytial Virus Infection Not recruiting United Kingdom
Phase I Study for SynGEM, an Intranasal Respiratory Syncytial Virus (RSV) Prefusion F Subunit Candidate Vaccine Not recruiting United Kingdom
A clinical trial which compares the effectiveness and safety of a not yet approved drug, called S-033188, versus placebo, and versus an approved drug (Oseltamivir) for 5 Days in Patients with Influenza at High Risk of Influenza Complications Not Available United Kingdom
A clinical trial which compares the effectiveness and safety of a not yet approved drug, called S-033188, versus placebo, and versus an approved drug (Oseltamivir) for 5 Days in Patients with Influenza at High Risk of Influenza Complications Not Available United Kingdom
A clinical trial which compares the effectiveness and safety of a not yet approved drug, called S-033188, versus placebo, and versus an approved drug (Oseltamivir) for 5 Days in Patients with Influenza at High Risk of Influenza Complications Not Available United Kingdom
A clinical trial which compares the effectiveness and safety of a not yet approved drug, called S-033188, versus placebo, and versus an approved drug (Oseltamivir) for 5 Days in Patients with Influenza at High Risk of Influenza Complications Authorised United Kingdom
A clinical trial which compares the effectiveness and safety of a not yet approved drug, called S-033188, versus placebo, and versus an approved drug (Oseltamivir) for 5 Days in Patients with Influenza at High Risk of Influenza Complications Authorised United Kingdom
A clinical trial which compares the effectiveness and safety of a not yet approved drug, called S-033188, versus placebo, and versus an approved drug (Oseltamivir) for 5 Days in Patients with Influenza at High Risk of Influenza Complications Authorised United Kingdom

Page last reviewed: 16/01/2015

Next review due: 01/09/2017